Article
Low-level resistance to rifampin in Streptococcus pneumoniae.
Antimicrobial agents and chemotherapy - 1 Mar 2003
Meier Patricia Stutzmann, Utz Silvia, Aebi Suzanne, Mühlemann Kathrin
Abstract excerpt
Rifampin is recommended for combination therapy of meningitis due to beta-lactam-resistant Streptococcus pneumoniae. High-level rifampin resistance (MIC, > or =4 mg/liter) has been mapped to point mutations in clusters I and III of rpoB of the pneumococcus. The molecular basis of low-level resistance (MICs, > or =0.5 and <4 mg/liter) was analyzed. Spontaneous mutants of clinical pneumococcal isolates were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
